Breast cancer in the lower jaw after reconstructive surgery with a pectoralis major myocutaneous flap (PMMC) - A case report by Nestle-Kraemling, C et al.
553 December 2, 2011 Eu  Ro  PE  an JouR  naL of MED  I  CaL RE  sEaRCH
Abstract
for  head  and  neck  as  well  as  for  oromaxillofacial
surgery, the use of the pectoralis major myocutaneous
(PMMC)  flap  is  a  standard  reconstructive  technique
after radical surgery for cancers in this region. we re-
port to our knowledge for the first development of
breast cancer in the PMMC flap in a 79 year old pa-
tient,  who  had  undergone  several  operations  in  the
past for recurring squamous cell carcinoma of the jaw.
the occurrence of a secondary malignancy within the
donor tissue after flap transfer is rare, but especially in
the case of transferred breast tissue and the currently
high incidence of breast cancer theoretically possible.
therefore  preoperative  screening  mammography
seems advisable to exclude a preexisting breast cancer
in  female  patients  undergoing  such  reconstruction
surgery. therapy for breast cancer under these circum-
stances is individual and consists of  radical tumor re-
section followed by radiation if applicable and a stan-
dard systemic therapeutic regimen on the background
of the patients individual prognosis due to the primary
cancer.
Key words: secondary malignancy - squamous cell car-
cinoma  - neck dissection -  recurrence – transplanted
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IntRoDuCtIon
the pectoralis major myocutaneous (PMMC) flap is a
standard reconstructive technique in patients with can-
cers in the neck and face and is able to cover major
anatomical defects arising from of such radical cancer
surgery. In general, transferred flap tissue includes the
skin, subcutaneous fat and the corresponding muscle
with a vascular pedicle. the recurrence of the original-
ly resected tumor or the development of cancer of the
skin  within  the  flap  tissue  is  extremely  rare  [1,  2].
However, the possibility of a new tumor arising from
the transplant tissue should be addressed before such
a procedure is performed. the PMMC flap, which was
first reported by ariyan in 1979, is one of the standard
reconstructive procedures after radical cancer surgery
for neck and face cancers. other indications include
the coverage of fistulas of the sternum, chest wall de-
fects and it is sometimes used for breast reconstruc-
tions after breast cancer surgery [3-5].
a particular characteristic of the PMMC flap is the
dissection of the skin-island with the underlying sub-
cutaneous tissue which invariably results in the trans-
plantation  of  some  breast  tissue.  also  due  to  the
anatomical variation of the female breast, particularly
the  spread  and  the  existence  of  aberrant  breast
parenchyma  may  invariably  result  in  some  glandular
epithelial tissue being transplanted. therefore, the oc-
currence of breast cancer in a PMMC flap is theoreti-
cally possible, considering the high incidence of this
malignancy.
In  this  presented  case,  the  patient  underwent
surgery for a primary neck cancer in 1994. several re-
currences in the following years required reoperations,
so that finally in 1997 the patient needed a PMMC flap
to  cover  the  anatomical  defect.  the  diagnosis  of
breast cancer in the PMMC tissue was confirmed four
years later in 2001, after the patient had presented her-
self to the hospital for a palpable mass in the flap.
this case underlines that development of primary
breast cancer in the transferred tissue should be kept
in mind as a differential diagnosis to local tumor re-
currence in a female patient. furthermore, a basic pre-
operative  apparative  screening  seems  reasonable  for
female patients prior to a PMMC flap surgery.
CasE REPoRt
the patient was initially diagnosed with a squamous
cell carcinoma of the right alveolar process. she then
underwent  a  neck  dissection,  resection  of  partial
mandible,  cheek  and  floor  of  the  mouth  with
mandible reconstruction using MRs plates in february
of 1994. the final histology revealed a pt4 pn0 g2
cM0. as a postoperative measure, the patient under-
went a percutaneous radiation of the mouth, orophar-
ynx and cervical lymph nodes with a total radiation
dosage of 60.2 gy directed to the region of the carci-
noma and 48.5 gy to the region of the lymph node
drainage. she was not administered any systemic thera-
py.  the  first  recurrence  was  diagnosesd  in  august
1995, whereby the tumor was surgically removed and
the anatomy reconstructed using a transposition flap.
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edge of the right tongue and required further surgery
including a right hemiglossectomy, partial right cheek
removal and the reconstruction with a PMMC flap. In
the operation report it was noted that the muscle tis-
sues were extremely hypotrophic, probably due to the
much reduced alimentary and nutritional condition of
the patient. Moreover, it described the dissection of
the  myocutaneous  pectoral  muscle  and  its  vascular
pedicle  of  the  thoracoacromial  artery  and  vein,  fol-
lowed by rotation as well as tunneling of the flap un-
der the right clavicle and along the carotid artery for
covering an oral defect of 6.5 x 4.5 cm2. During rou-
tine follow-ups, a biopsy was taken in april 1998 from
the base of the tongue due to a palpable mass in close
proximity to the PMMC flap revealing a fibroma. In
february 1999, the patient was diagnosed with a sec-
ond carcinoma originating from the alveolar process
of the right upper jaw. this resulted in partial maxil-
lary excision and the histology showed a 1.6 cm in dia  -
meter measuring squamous cell carcinoma. the mar-
gins showed dysplasia and chronic inflammation free
of malignancy. 
finally, in september 2001 as part of the routine
follow-ups, the patient was diagnosed with an extra  -
oral palpable and indurate mass. ultrasonographically
an  inhomogenous  and  markedly  hypoechoic  lesion 
in the area of the PMMC flap was detected. a core
needle biopsy taken from the lesion showed an inva-
sive ductal breast carcinoma. following the diagnosis,
the  patient  was  transferred  to  our  unit  for  further
work-up. 
the clinical examination revealed a patient with ob-
vious  cachexia  weighing  43  kg  with  165  cm  body
height.  Her  medical  history  was  uneventful  for  any
other illnesses, apart from the above mentioned and
her gynecological history just revealed an abrasion in
1957 and a senile kolpitis at present, being under ther-
apy with topical applications of an estrogen-contain-
ing ointment for approximately 6-9 months. she was a
gravida  II,  para  II  with  uneventful  pregnancies  and
normal labor. the family history was non-contributory
for genetic disorders or breast cancer, but one of her
sons had died at the age of 45 years due to a rare ma-
lignancy of the adrenal cortex.
the inspection and palpation of the right cheek and
lower  jaw  showed  induration  and  multiple  scars  as
shown in fig.1 and a palpable mass measuring approx-
imately 2 x 1.5 cm. the sonography of the mass re-
vealed a hypoechoic lesion measuring1.2x1.4x1.8 cm,
which could be interpreted as a tumor lesion or a post-
operative  scar.  the  inspection  of  the  hypoplastic
breasts was unremarkable for palpable masses, indura-
tions or nipple discharge. the inspection of the axil-
lary  lymph  nodes  was  unremarkable  for  enlarged
nodes. the ultrasound of the breast and axilla did not
reveal any suspicious lesions. the screening mammog-
raphy was evaluated as BIRaDs II, showing only un-
suspicious monomorphic microcalcification on the left
breast. further examination of the patient including
vaginal  sonography,  cervical  PaP  smear  and  tumor
marker analysis was also unremarkable. 
the patient was then operated by our oromaxillo  -
facial surgery unit and a tumor measuring 3 x 1.2 x
1cm3 was  excised.  the  histology  this  time  revealed
glandular structures near the pectoral muscle with en-
larged ducts showing apocrine metaplasia and ductal
hyperplasia as well as a low differentiated adenocarci-
noma classified as an invasive ductal carcinoma of the
breast  with  infiltration  of  the  surrounding  adipose 
tissues. the tumor was shown to be positive for estro-
gen,  but  negative  for  progesterone  receptors.  the
HER2neu  over  expression  was  defined  as  +1  on  a
scale of 0-3 using the DaKo-Hercepﾮ test. the im-
munohistochemistry  showed  a  diffuse  positive  reac-
tion for cytokeratin 7 and a negative reaction for cy-
tokeratin 5/6. Due to the positive margins a local re-
excision  was  performed  in  october  2001.  However,
the histology of the latter operation did not show any
residues of the breast cancer. a sequential radiothera-
py could not be performed, since the patient had al-
ready been radiated locally to a maximal tolerable dose
in 1994. 
furthermore, the patient received 20 mg tamoxifen
orally per day as an systemic adjuvant therapy for the
receptor positive breast malignancy beginning Decem-
ber 2001 for 6 months. Due to the development of se-
vere side effects as well as endometrium irregularity
revealed in a transvaginal sonography (finally clarified
as  a  benign  endometrium  polyp),  tamoxifen  was
switched to the aromatase inhibitor anastrozol (1 mg
orally per day). the patient is under regular follow-ups
and to date over 9 years free of any signs of recur-
rence.
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Fig 1. the amount of transferred breast tissue can be esti-
mated by the location and length of the s-shaped scar result-
ing from the PMMC flap elevation on the craniolateral area
of the right breast. Induration and scar tissue in the region of
the right jaw marks the area of breast cancer resection of the
inlayed PMMC flap.
7) Nestle-Kraemling###_Umbruchvorlage  14.11.11  11:28  Seite 554DIsCussIon
the pectoral major myocutaneous flap, as described
by ariyan [6] in the late 70ﾴs, is the “working horse” of
reconstructive surgery after radical tumor resection of
the head and neck region. the large number of publi-
cations  since  then  have  concentrated  mainly  on  the
operation  technique,  indications  and  complications
that  might  arise  as  a  result  of  this  flap  surgery.  In
terms of the blood supply, the method seems to be
relatively safe with reported complication rates varying
between 8.5% to 35%, regarding the high morbidity of
these patients. several modifications of the technique
have also been reported. one modification is called
the pectoralis major myofascial (PMMf) flap which in-
cludes raising the muscle and muscle fascia but with-
out the skin or breast parenchyma. the major advan-
tage of this flap technique is seen in less bulge forma-
tion in the jaw region and a better shaping ability [7]. 
In terms of the blood supply, it also seems to have
a higher safety [8, 9]. the complication rates of this
procedure are largely made up of approximately 8.5%
flap  necrosis,  of  which  1.5%  are  complete  necrosis
and 18.5% wound healing problems mostly associated
with the reported 13.5% orocutaneous fistulas [4]. In
subgroups of patients with preexistent chronic medi-
cine disorders, the total complication rate has been re-
ported to as high as 27% compared to patients with-
out  any  preexisting  disorders,  showing  complication
rates of around 8.5%. In the largest published data en-
closing 244 patients, the authors report a total compli-
cation rate of 35% which include all possible and also
minor  complications  such  as  hematoma,  infection,
seroma, dehiscence, fistulas, partial or complete necro-
sis or other rare complications [10].
However,  the  theoretic  and  remote  possibility  of
the development of breast cancer due to transplanted
breast parenchyma has so far not been documented.
the indication for a PMMC flap is usually seen only in
surgery for recurrences or advanced primary carcino-
mas. Due to the relatively poor prognosis of these pa-
tients, the rare and late onset complication of a new
primary tumor arising within the flap tissue is usually
not of major concern. However, in patients with cured
primary cancer the development of a breast carcinoma
in such transplants has to be associated with a poor
prognosis which mainly results from its difficult diag-
nosis.
up to now there is no general consensus for breast
cancer screening in patients undergoind PMMC flap;
therefore these patients are not routinely screened. ac-
cording to the literature, only 7 to 22% of all patients
undergoing a PMMC flap reconstruction are female [4,
11, 12]. the average age at time of operation varied
between 36 and 59 years. Most patients were operated
due to an advanced primary oropharynx carcinoma or
a tumor recurrence. the development of such a carci-
noma in patients without risk factors as nicotine or al-
cohol as in our patient is rare and may generally reflect
a predisposition towards tumor development. a molec-
ular genetic hallmark of the squamous cell carcinomas
of the oropharynx in female patients without any risk
factors  is  the  frequent  finding  of  a  p53  mutation
and/or positive HPv test. Distinct from this group of
patients, there are some patients with genetic germ line
mutation  of  p53,  also  called  the  Li  fraumeni  syn-
drome,  with  a  familial  predisposition  to  this  type  of
carcinoma as well as to breast carcinoma.
It seems reasonable to perform mammography and
additional breast ultrasound as a preoperative measure
in female patients being considered for a PMMC flap.
with these routine diagnostic tools it should be possi-
ble to gain information on the distribution of breast
parenchyma including aberrant breast tissue and thus
help to prevent early manifestation or transplantation
of preneoplasia or non palpable breast cancer. In this
case, the time course from flap surgery to diagnosis of
breast cancer was approximately 4 years and therefore
any  screening  at  time  of  transplantation  may  have
been unremarkable. the promotion of breast cancer
due to short term recent topical estrogen-therapy be-
cause of senile kolpitis seems unlikely but can not be
completely  excluded.  the  use  of  an  aromatase  in-
hibitor as an adjuvant systemic endocrine therapy in
this hormone receptor positive patient seems to be ad-
equate. It also avoids the additional risk elevation for
endometrial carcinoma under tamoxifen. after 9 years
the patient is free of any relapses due to the cancer
from the oropharynx and the breast. In case of future
metastasis, it is pertinent to histologically confirm the
origin of the metastatic tissue, before any therapy is
initiated or changed.
Part of this work was already published in oral oncology
EXtRa (2005) 41, 238–241
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